REVEAL BIOSCIENCES
LIVE

Serial Number

97433162

Owner

Reveal Biosciences, Inc.

Attorney

Keith Toms, Esq.

Filing Date

May 27, 2022

Add to watchlist:

No watchlists yet
View on USPTO

REVEAL BIOSCIENCES Trademark

Serial Number: 97433162

REVEAL BIOSCIENCES is a trademark filed by Reveal Biosciences, Inc. on May 27, 2022. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Reveal Biosciences, Inc. (5 trademarks)

6760 Top Gun, Suite 110
San Diego, CA 92121

Entity Type: 03

Trademark Details

Filing Date

May 27, 2022

Registration Date

Not Registered

Goods & Services

Clinical pathology services; clinical histology services; consulting services in the field of pathology and histology; medical consultations; consulting services provided by specialized medical personnel, namely, veterinary and anatomic pathologists; medical imaging services; clinical medical services in the field of pathology, histology, immunohistochemistry, immunofluorescence, and in situ hybridization

Downloadable software for human and animal tissue processing and analysis; Downloadable software for image processing and analysis; Downloadable software for producing quantitative Nonalcoholic fatty liver disease (NAFLD) activity scoring and quantitative fibrosis scoring; Downloadable electronic data files featuring pathology, microscopy, and histology images and data; Downloadable electronic data files featuring images and data for use in preclinical research, clinical trials, and decision support; Downloadable files containing digital assays; Downloadable image files containing biological tissue samples and medical tissue samples; Downloadable images in the field of pathology, histology, immunohistochemistry, immunofluorescence, and in situ-hybridization; Downloadable scientific and medical data via the internet; Specimen collection kits, comprised of specimen containers, vials, caps, and microscope slides; Specimen collection kits for clinical trial research, comprised of specimen containers, vials, caps, and microscope slides; plastic and glass tubes and vials for research sample collection and storage; laboratory equipment, namely, microscope slides; wipes and swabs for use in collecting samples for laboratory and clinical trial research; Testing sample collection equipment, namely, wipes, swabs, tubes, vials, and for use in experimental testing, not for medical purposes

Scientific research and development; Medical research and development; Product research and development; Biochemical research and development; Pharmaceutical research and development services; Biomedical research and development services; Design and development of biochemical, pharmaceutical, and medical assays; Scientific and pharmaceutical research in the field of biomarker discovery; Conducting clinical trials for others; Conducting clinical trials for others in the fields of pharmaceutical, medical, and scientific research; Consulting services for others in the field of design, planning, and implementation project management of clinical trials; Conducting research and clinical trials for others in the fields of oncology, infectious diseases, autoimmune disorders, and allergies; Consulting services in the field of clinical trial research; Providing medical and scientific research information in the field of clinical trials; Research and development in the pharmaceutical and biotechnology fields; Laboratory research services relating to pharmaceuticals; Research services in the field of pathology; Software as a Service (SaaS) service for human and animal tissue processing; Software as a Service (SaaS) services for storing slide images and image management; Software as a Service (SaaS) for slide scanning and imaging instruments; Software as a service (SAAS) services featuring software for managing, processing and analyzing pathology, microscopy, and histology data; Software as a service (SAAS) services featuring software for use in the medical imaging field, namely, pathology, microscopy, and histology, for performing digital image management; Software as a service (SAAS) services featuring software for use in the medical imaging field, namely, pathology, microscopy, and histology for enabling remote or local viewing, annotating, and analysis of digital images; Software as a service (SAAS) services featuring software for image management and analysis; Software as a service (SAAS) services featuring software for use in the electronic storage of data, images and files; Software as a service (SAAS) services featuring software for managing, reviewing and analyzing digital assays; Software as a service (SAAS) services featuring software for processing medical images; Software as a service (SAAS) services featuring software for use in the diagnosis of diseases, states, or conditions; Software as a service (SAAS) services featuring software for artificial intelligence, machine learning, deep learning, statistical learning, data mining, and contextual prediction; Software as a service (SAAS) services featuring software using artificial intelligence for processing and analyzing medical images; Providing a web site featuring technology that enables users to find and match with appropriate pathology professionals; Providing a web site featuring technology that enables users to interact with and exchange data, images and files with pathology professionals; Scientific and technological services, namely, scientific research, analysis, and testing in the fields of pathology, histology, medical images, and related research and design services; scientific and technological services, namely, providing management, processing and analysis of digital images in the fields of pathology and histology; research and development and consultation related thereto in the field of pathology, histology, and medical imaging; research and development and consultation related thereto in the field of medicine for the diagnosis of clinical pathologies; research and development and consultation related thereto in the field of digital assays; medical and scientific research services for others in the fields of pathology, histology, immunohistochemistry, immunofluorescence, in situ-hybridization, and medical imaging; medical and scientific research services for others, namely, research and design in the field of testing, analyzing and examining biological tissue samples and medical tissue samples; research in the field of artificial intelligence

Filing History

NOTIFICATION OF FINAL REFUSAL EMAILED
Jul 30, 2026 GNFN
FINAL REFUSAL E-MAILED
Jul 30, 2026 GNFR
FINAL REFUSAL WRITTEN
Jul 30, 2026 CNFR
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
May 31, 2026 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Nov 5, 2025 RCSC
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Nov 4, 2025 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Apr 30, 2025 RCSC
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Apr 30, 2025 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Oct 30, 2024 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Oct 29, 2024 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Dec 13, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Dec 13, 2023 GNSL
SUSPENSION LETTER WRITTEN
Dec 13, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 11, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 10, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 10, 2023 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jul 6, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jul 6, 2023 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 11, 2023 GNRN
NON-FINAL ACTION E-MAILED
Apr 11, 2023 GNRT
NON-FINAL ACTION WRITTEN
Apr 11, 2023 CNRT
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 11, 2023 GNRN
NON-FINAL ACTION E-MAILED
Apr 11, 2023 GNRT
NON-FINAL ACTION WRITTEN
Apr 11, 2023 CNRT
ASSIGNED TO EXAMINER
Mar 14, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 7, 2022 NWOS
NEW APPLICATION ENTERED
May 31, 2022 NWAP